封面
市场调查报告书
商品编码
1796891

先进球囊导管市场-全球产业规模、份额、趋势、机会和预测,按原料类型、应用、最终用户、地区和竞争细分,2020-2030 年

Advanced Balloon Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Raw Material Type, By Application, End Users, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球高级球囊导管市场价值为 42.2 亿美元,预计到 2030 年将达到 71.9 亿美元,预测期内的复合年增长率为 9.29%。全球高级球囊导管市场正在经历显着增长,这得益于该地区各种慢性心臟病患病率的上升和老龄人口的增长。新兴国家对微创手术的需求不断增长,以及先进心血管设备的发展,将在预测期内进一步增强球囊导管的整体市场需求。其他支持市场成长的因素包括影响泌尿系统的骨盆腔癌症发生率不断上升,以及旨在将药物输送到作用部位的药物涂层球囊导管的技术发展,预计这些都将推动市场的成长。

市场概览
预测期 2026-2030
2024年市场规模 42.2亿美元
2030年市场规模 71.9亿美元
2025-2030 年复合年增长率 9.29%
成长最快的领域 神经血管手术
最大的市场 北美洲

关键市场驱动因素

心血管和周边动脉疾病发生率上升

主要市场挑战

先进设备和程序的成本高昂

主要市场趋势

药物涂层球囊(DCB)的使用日益增多

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球先进球囊导管市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依原料种类(尼龙、PET、聚氨酯、其他)
    • 依应用(冠状动脉手术、週边手术、神经血管手术、其他手术)
    • 按最终使用者(医院和门诊手术中心、导管室等)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美高级球囊导管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲先进球囊导管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太地区高级球囊导管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲高级球囊导管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章:中东和非洲高级球囊导管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 併购
  • 产品发布

第 13 章:全球高级球囊导管市场:SWOT 分析

第 14 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章:竞争格局

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Meril Life Sciences Pvt. Ltd.
  • Hexacath
  • Tokai Medical Products Inc.
  • Cook Medical Inc.

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 14331

Global Advanced Balloon Catheter Market was valued at USD 4.22 billion in 2024 and is expected to reach USD 7.19 billion by 2030 with a CAGR of 9.29% during the forecast period. The global market for Advanced Balloon Catheter is experiencing significant growth, driven by the rising prevalence of different chronic heart diseases and growing geriatric populations across the region. The increasing demand for minimally invasive procedures in emerging countries and the development of advanced cardiovascular devices will further enhance the overall market demand for balloon catheters during the forecast period. The other factors supporting the market's growth are the growing incidence of cancers in the pelvic region affecting the urinary system along with the technical development of drug-coated balloon catheters aimed at drug delivery at the site of action is expected to propel the growth of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.22 Billion
Market Size 2030USD 7.19 Billion
CAGR 2025-20309.29%
Fastest Growing SegmentNeurovascular Procedures
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Cardiovascular and Peripheral Arterial Diseases

The global burden of cardiovascular disease (CVD) continues to be a leading cause of death and disability. According to the World Health Organization (WHO), CVDs account for over 17.9 million deaths annually, making them the top cause of mortality worldwide. A substantial proportion of these cases involve atherosclerosis, coronary artery disease (CAD), and peripheral artery disease (PAD)all conditions for which balloon catheters are a critical component of diagnosis and treatment, particularly in angioplasty procedures.

Balloon catheters help open narrowed or blocked blood vessels without requiring more invasive surgeries, which has made them highly favored in both emergency and elective interventions. In regions with aging populations, especially North America and parts of Europe, the demand for minimally invasive vascular procedures has steadily increased due to the higher prevalence of hypertension, diabetes, and obesity.

Key Market Challenges

High Cost of Advanced Devices and Procedures

One of the most pressing challenges facing the global advanced balloon catheter market is the high cost associated with these devices, which can limit their accessibility, especially in low- and middle-income countries. Drug-coated and specialty catheters are significantly more expensive than conventional balloon catheters, making their widespread use a financial burden for both healthcare systems and patients. Even in high-income countries, insurance coverage does not always fully reimburse advanced interventional procedures. In publicly funded healthcare systems, budget constraints and cost-containment policies often result in delayed or limited adoption of newer, costlier technologies. The challenge is further compounded by the need for specialized training and infrastructure, which increases the total cost of ownership for hospitals and surgical centers.

Government funding programs, while helpful, are often insufficient to address the gap in demand for cutting-edge equipment versus what is affordable or reimbursable. This disparity limits the penetration of advanced balloon catheter technology in various parts of the world, hindering equitable healthcare delivery.

Key Market Trends

Growing Use of Drug-Coated Balloons (DCBs)

Drug-coated balloons are gaining significant traction as they offer a stent-less solution for revascularization. These devices are particularly useful in treating in-stent restenosis (ISR) and femoral-popliteal lesions, where stents may not be ideal due to anatomical or movement-related factors. The appeal of DCBs lies in their ability to deliver therapeutic agents like paclitaxel directly into the vessel wall during a short inflation time, reducing the risk of chronic inflammation and improving healing outcomes.

Healthcare systems are showing increasing interest in DCBs, especially for peripheral interventions. Clinical trials supported by government agencies such as the National Institutes of Health (NIH) in the U.S. have investigated the long-term efficacy and safety of these devices, providing a research-backed push toward greater adoption. This trend is expected to grow further as more biocompatible and biodegradable drug coatings are introduced and regulatory bodies clarify safety profiles, making DCBs a mainstay in future vascular treatments.

Key Market Players

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Meril Life Sciences Pvt. Ltd.
  • Hexacath
  • Tokai Medical Products Inc.
  • Cook Medical Inc.

Report Scope:

In this report, the Global Advanced Balloon Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Balloon Catheter Market, By Raw Material Type:

  • Nylon
  • PET
  • Polyurethane
  • Others

Advanced Balloon Catheter Market, By Application:

  • Coronary Procedures
  • Peripheral Procedures
  • Neurovascular Procedures
  • Other Procedures

Advanced Balloon Catheter Market, By End User:

  • Hospitals and Ambulatory Surgical Centres
  • Catheterization Laboratories
  • Others

Advanced Balloon Catheter Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Advanced Balloon Catheter Market.

Available Customizations:

Global Advanced Balloon Catheter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Advanced Balloon Catheter Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 5.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 5.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Advanced Balloon Catheter Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 6.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 6.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Advanced Balloon Catheter Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Raw Material Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Advanced Balloon Catheter Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Raw Material Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Advanced Balloon Catheter Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Raw Material Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Advanced Balloon Catheter Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 7.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 7.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Advanced Balloon Catheter Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Raw Material Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Advanced Balloon Catheter Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Raw Material Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Advanced Balloon Catheter Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Raw Material Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Advanced Balloon Catheter Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Raw Material Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Advanced Balloon Catheter Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Raw Material Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Advanced Balloon Catheter Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 8.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 8.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Advanced Balloon Catheter Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Raw Material Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Advanced Balloon Catheter Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Raw Material Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Advanced Balloon Catheter Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Raw Material Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Advanced Balloon Catheter Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Raw Material Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Advanced Balloon Catheter Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Raw Material Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Advanced Balloon Catheter Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 9.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 9.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Advanced Balloon Catheter Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Raw Material Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Advanced Balloon Catheter Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Raw Material Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Advanced Balloon Catheter Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Raw Material Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Advanced Balloon Catheter Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 10.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 10.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Advanced Balloon Catheter Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Raw Material Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Advanced Balloon Catheter Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Raw Material Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Advanced Balloon Catheter Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Raw Material Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Advanced Balloon Catheter Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Boston Scientific Corporation
  • 15.3. Medtronic plc
  • 15.4. Terumo Corporation
  • 15.5. MicroPort Scientific Corporation
  • 15.6. B. Braun Melsungen AG
  • 15.7. Meril Life Sciences Pvt. Ltd.
  • 15.8. Hexacath
  • 15.9. Tokai Medical Products Inc.
  • 15.10. Cook Medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer